Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | A |
3. Samples | A |
4. Measurand | A |
5. Pre-Analytical | A |
6. Replicate Analysis | B |
7. Steady State | A |
8. Outlier Analysis | C |
9. Normality | B |
10. Variance Homogeneity | C |
11. ANOVA | B |
12. CI | C |
13. No of Results | C |
14. Concentrations | A |
15. Total Score | C8,10,12,13 |
Comment | C8,10,12 |
Parameter | Score |
---|---|
Matrix | Serum |
Measurand | Cancer antigen 19-9 (CA 19-9) |
Unit | ku / L |
Overall Analytical Principle Method | Immunoassay; Not specified |
Number of Subjects | 17 |
Number of Subjects included in BV estimation | 17 |
Ethinicity | Unknown |
Age Mean / Median | 30.0 |
Age Min | |
Age Max | |
Age SD | |
Number of Males | 9 |
Number of Females | 8 |
State of Well Being |
Non-healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 2 |
Study Duration Units | Month |
Sampling Intervals, e.g. X sample(s) per Interval Unit | 3 |
Interval Units | Month |
Sampling Times | Start Time:
End Time: |
Number of Samples | 6 |
Average Number of Samples Used for BV Estimation | 6.0 |
Average Number of Replicates | 1.0 |
Estimates of CVi | 15.9 |
Calculated Confidence Intervals of CVi | Lower: 13.75, Upper: 18.78 |
Estimates of CVg | 159.0 |
Calculated Confidence Intervals of CVg | Lower: 119.23, Upper: 238.48 |
Analytical CV | 2.7 |
Calculated Confidence Intervals of Analytical CV | Lower: 1.89, Upper: 4.74 |
Measurand Mean | 17.1 |
Measurand Min | |
Measurand Max | |
Measurand SD |